Search

Displaying results 8751 - 8760 of 10000 in total
  1. Drug

    Troxacitabine

    go.drugbank.com/drugs/DB04961
    Investigational

    Troxacitabine is a nucleoside analog with antineoplastic activity. There has been growing interest in its development for the treatment of patients with refractory lymphoproliferative conditions.

  2. Drug

    Protiofate

    go.drugbank.com/drugs/DB13632
    Experimental

    Categories: Genito Urinary System and Sex Hormones, Gynecological Antiinfectives and Antiseptics
  3. Drug

    Onfekafusp alfa

    go.drugbank.com/drugs/DB16269
    Investigational

    Onfekafusp alfa is under investigation in clinical trial NCT02938299 (Neoadjuvant L19IL2/L19TNF- Pivotal Study).

    Categories: bifikafusp alfa and onfekafusp alfa, Antineoplastic and Immunomodulating Agents
  4. Drug

    Anethole

    go.drugbank.com/drugs/DB15916
    ApprovedWithdrawn

    Categories: Diet, Food, and Nutrition
  5. Drug

    FK-960

    go.drugbank.com/drugs/DB06465
    Experimental

  6. Drug

    Gestonorone

    go.drugbank.com/drugs/DB13230
    Experimental

    Gestonorone is often mistaken for gestonorone capproate which has a different chemical structure.

    Categories: Hormones and Related Agents, Genito Urinary System and Sex Hormones
  7. Drug

    Acetyldihydrocodeine

    go.drugbank.com/drugs/DB01538
    ExperimentalIllicit

    Categories: Cough and Cold Preparations, Opium Alkaloids and Derivatives
  8. Drug

    Thebacon

    go.drugbank.com/drugs/DB13458
    Experimental

    Categories: Cough and Cold Preparations, Opium Alkaloids and Derivatives
  9. Drug

    Recainam

    go.drugbank.com/drugs/DB20085
    Experimental

    The usage of the INN stem '-cain-' in the name indicates that Recainam is a class I antiarrhythmic, procainamide and lidocaine derivative. Recainam has a monoisotopic molecular weight of 263.2 Da.

  10. Drug

    GZ-389988

    go.drugbank.com/drugs/DB16056
    Investigational

    GZ-389988 is under investigation in clinical trial NCT02845271 (Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients